Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP1585 in CKD Patients with Hyperphosphatemia on Peritoneal Dialysis
NCT01017276Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Nov 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric citrate in hyperphosphatemia, sponsored by Astellas Pharma. Started Nov 2009; status: completed.
02
Drugs
ferric citrate
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT01017276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017276.